In Silico Methods for Predicting Drug Toxicity

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Methods in Molecular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/978-1-4939-3609-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mixture Toxicity: Linking Approaches from Ecological and Human Toxicology

  2016cited by this paper
• Can Toxicity for Different Species be Correlated?: The Concept and Emerging Applications of Interspecies Quantitative Structure-Toxicity Relationship (i-QSTR) Modeling

  2016cited by this paper
• CERAPP: Collaborative Estrogen Receptor Activity Prediction Project

  2016cited by this paper
• Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.

  2015cited by this paper
• Importance of Applicability Domain of QSAR Models

  2015cited by this paper
• Methods of integrating data to uncover genotype–phenotype interactions

  2015cited by this paper
• Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure.

  2015influential reference
• Big Data: Hype and Reality

  2015cited by this paper
• (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.

  2015cited by this paper
• Predicting idiosyncratic drug-induced liver injury – some recent advances

  2014cited by this paper
• Application of Systems Pharmacology to Explore Mechanisms of Hepatotoxicity

  2014cited by this paper
• Use of a systems model of drug-induced liver injury (DILIsym(®)) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice.

  2014cited by this paper
• Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how.

  2014cited by this paper
• A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the ‘rule-of-two’ model

  2014cited by this paper
• A k-NN algorithm for predicting the oral sub-chronic toxicity in the rat.

  2014cited by this paper
• SEURAT: Safety Evaluation Ultimately Replacing Animal Testing—Recommendations for future research in the field of predictive toxicology

  2014cited by this paper
• Evaluation of QSAR Models for the Prediction of Ames Genotoxicity: A Retrospective Exercise on the Chemical Substances Registered Under the EU REACH Regulation

  2014cited by this paper
• Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.

  2014cited by this paper
• Steroid signaling: ligand-binding promiscuity, molecular symmetry, and the need for gating.

  2014cited by this paper
• Progress in computational toxicology.

  2014cited by this paper
• Adverse outcome pathway development II: best practices.

  2014cited by this paper
• Assessing compound carcinogenicity in vitro using connectivity mapping.

  2014cited by this paper
• Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?

  2014cited by this paper
• Self organising hypothesis networks: a new approach for representing and structuring SAR knowledge

  2014cited by this paper
• Adverse outcome pathway (AOP) development I: strategies and principles.

  2014cited by this paper
• REACH and in silico methods: an attractive opportunity for medicinal chemists.

  2014cited by this paper
• Computational Derivation of Structural Alerts from Large Toxicology Data Sets

  2014cited by this paper
• diXa: a data infrastructure for chemical safety assessment

  2014cited by this paper
• Toward predictive models for drug-induced liver injury in humans: are we there yet?

  2014cited by this paper
• High Daily Dose and Being a Substrate of Cytochrome P450 Enzymes Are Two Important Predictors of Drug-Induced Liver Injury

  2014cited by this paper
• In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme.

  2014cited by this paper
• Standardizing Benchmark Dose Calculations to Improve Science-Based Decisions in Human Health Assessments

  2014cited by this paper
• Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants

  2014cited by this paper
• Effects of carbon tetrachloride on oxidative stress, inflammatory response and hepatocyte apoptosis in common carp (Cyprinus carpio).

  2014cited by this paper
• Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists

  2014cited by this paper
• Versatility or Promiscuity: The Estrogen Receptors, Control of Ligand Selectivity and an Update on Subtype Selective Ligands

  2014cited by this paper
• The eTOX Data-Sharing Project to Advance in Silico Drug-Induced Toxicity Prediction

  2014cited by this paper
• ToxRead: A tool to assist in read across and its use to assess mutagenicity of chemicals£

  2014cited by this paper
• QSAR modeling: where have you been? Where are you going to?

  2014cited by this paper
• Acrolein-Induced Oxidative Stress and Cell Death Exhibiting Features of Apoptosis in the Yeast Saccharomyces cerevisiae Deficient in SOD1

  2014cited by this paper
• Pattern discovery and cancer gene identification in integrated cancer genomic data

  2013cited by this paper
• The Need for Combination Drug Therapies in Patients with Complex Dyslipidemia

  2013cited by this paper
• The adverse outcome pathway concept: a pragmatic tool in toxicology.

  2013cited by this paper
• Chapter 7:Evaluation of Categories and Read-Across for Toxicity Prediction Allowing for Regulatory Acceptance

  2013cited by this paper
• EADB: an estrogenic activity database for assessing potential endocrine activity.

  2013cited by this paper
• Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays

  2013cited by this paper
• Automatic knowledge extraction from chemical structures: the case of mutagenicity prediction

  2013cited by this paper
• High lipophilicity and high daily dose of oral medications are associated with significant risk for drug‐induced liver injury

  2013cited by this paper
• Adverse outcome pathways during zebrafish embryogenesis: a case study with paraoxon.

  2013cited by this paper
• Preliminary Studies on Model Development for Rodent Toxicity and Its Interspecies Correlation with Aquatic Toxicities of Pharmaceuticals

  2013cited by this paper
• Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database

  2013cited by this paper
• A comparative survey of chemistry-driven in silico methods to identify hazardous substances under REACH.

  2013cited by this paper
• The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point

  2013cited by this paper
• QSAR and metabolic assessment tools in the assessment of genotoxicity.

  2013cited by this paper
• Hazard Evaluation Support System (HESS) for predicting repeated dose toxicity using toxicological categories

  2013cited by this paper
• ToxML, a data exchange standard with content controlled vocabulary used to build better (Q)SAR models

  2013cited by this paper
• Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.

  2013cited by this paper
• Chapter 1:An Introduction to Chemical Grouping, Categories and Read-Across to Predict Toxicity

  2013cited by this paper
• Drug-induced liver injury: mechanisms, types and biomarkers.

  2013cited by this paper
• Evaluation of the Toxicity Forecasting Capability of EPA's ToxCast Phase I Data: Can ToxCast In Vitro Assays Predict Carcinogenicity?

  2013cited by this paper
• Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.

  2013cited by this paper
• Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury.

  2013cited by this paper
• The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing

  2013cited by this paper
• Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells.

  2013cited by this paper
• In silico methods to predict drug toxicity.

  2013cited by this paper
• Trial Watch: Phase II and Phase III attrition rates 2011–2012

  2013cited by this paper
• A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.

  2013cited by this paper
• Bacterial mutagenicity screening in the pharmaceutical industry.

  2013cited by this paper
• In vitro models for liver toxicity testing.

  2013cited by this paper
• Effects of multiple conformers per compound upon 3-D similarity search and bioassay data analysis

  2012cited by this paper
• Simultaneous determination of veterinary antibiotics and hormone in broiler manure, soil and manure compost by liquid chromatography-tandem mass spectrometry.

  2012cited by this paper
• Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs: Opportunities Provided by Physicochemical Property Modulation, In Silico Modeling, and Structural Modification

  2012cited by this paper
• Quantifying the chemical beauty of drugs.

  2012cited by this paper
• Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal.

  2012cited by this paper
• Inroads to Predict in Vivo Toxicology—An Introduction to the eTOX Project

  2012cited by this paper
• Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies.

  2012cited by this paper
• Challenges and directions for regulatory use of QSARs for predicting active pharmaceutical ingredients environmental toxicity.

  2012cited by this paper
• admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties

  2012cited by this paper
• A MATLAB toolbox for Self Organizing Maps and supervised neural network learning strategies

  2012cited by this paper
• A decade of toxicogenomic research and its contribution to toxicological science.

  2012cited by this paper
• Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.

  2012cited by this paper
• Applicability of Standard Antibiotic Toxicity Tests to the Ambient Aquatic Environment

  2012influential reference
• (Q)SAR Modeling and Safety Assessment in Regulatory Review

  2012cited by this paper
• Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.

  2012cited by this paper
• Latest advances in computational genotoxicity prediction

  2012cited by this paper
• The exposure data landscape for manufactured chemicals.

  2012cited by this paper
• Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management.

  2012cited by this paper
• Modeling Chemical Interaction Profiles: I. Spectral Data-Activity Relationship and Structure-Activity Relationship Models for Inhibitors and Non-inhibitors of Cytochrome P450 CYP3A4 and CYP2D6 Isozymes

  2012cited by this paper
• Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities

  2012cited by this paper
• Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?

  2012cited by this paper
• Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results

  2012cited by this paper
• Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients

  2012cited by this paper
• Risk assessment for ecotoxicity of pharmaceuticals – an emerging issue

  2012cited by this paper
• Modeling Chemical Interaction Profiles: II. Molecular Docking, Spectral Data-Activity Relationship, and Structure-Activity Relationship Models for Potent and Weak Inhibitors of Cytochrome P450 CYP3A4 Isozyme

  2012cited by this paper
• Optimizing Predictive Performance of CASE Ultra Expert System Models Using the Applicability Domains of Individual Toxicity Alerts

  2012cited by this paper
• Novel insight into mechanisms of cholestatic liver injury.

  2012cited by this paper
• Modeling Drug- and Chemical-Induced Hepatotoxicity with Systems Biology Approaches

  2012cited by this paper
• In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.

  2012cited by this paper
• Genotoxic Impurities in Pharmaceuticals

  2012cited by this paper
• Nutritional metabolomics: progress in addressing complexity in diet and health.

  2012cited by this paper

• Resolving data gaps in the acute toxicity profile of phosgene oxime (CX): a comprehensive in silico evaluation.

  2025cites this paper
• Development of Machine Learning‐Based Models for Mutagenicity Predictions with Applications to Non‐Sugar Sweeteners

  2025cites this paper
• Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study

  2024cites this paper
• Computational Tools to Facilitate Early Warning of New Emerging Risk Chemicals

  2024cites this paper
• Transporter proteins knowledge graph construction and its application in drug development

  2023cites this paper
• In Silico Drug Design of Anti-Breast Cancer Agents

  2023cites this paper
• Population responses of Daphnia laevis to endocrine disruptors: a molecular docking by binding active site to arginine kinase

  2023cites this paper
• The VEGA Tool to Check the Applicability Domain Gives Greater Confidence in the Prediction of In Silico Models

  2023cites this paper
• Antimicrobial Transformation Products in the Aquatic Environment: Global Occurrence, Ecotoxicological Risks, and Potential of Antibiotic Resistance

  2023cites this paper
• Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study

  2022cites this paper
• Human-Based New Approach Methodologies in Developmental Toxicity Testing: A Step Ahead from the State of the Art with a Feto–Placental Organ-on-Chip Platform

  2022cites this paper
• The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach

  2022cites this paper
• Quantitative Measurements of Pharmacological and Toxicological Activity of Molecules

  2022cites this paper
• Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD)

  2022cites this paper
• 'In silico' toxicology methods in drug safety assessment

  2021cites this paper
• Towards a systematic use of effect biomarkers in population and occupational biomonitoring.

  2021cites this paper
• Design, Synthesis and Antifungal Activity of New Schiff Bases Bearing 2-Aminothiophene Derivatives Obtained by Molecular Simplification

  2021cites this paper
• HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data

  2021cites this paper
• SYNTHESIS, IN SILICO CHARACTERIZATION AND EX VIVO EVALUATION OF THE NOVEL ORGANIC NITRATE NDIBP AS A POTENTIAL VASORELAXANT AGENT

  2021cites this paper
• Predicting the potential toxicity of 26 components in Cassiae semen using in silico and in vitro approaches

  2021cites this paper
• Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies

  2021cites this paper
• The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes

  2021cites this paper
• GC–MS Analysis, Molecular Docking and Pharmacokinetic Properties of Phytocompounds from Solanum torvum Unripe Fruits and Its Effect on Breast Cancer Target Protein

  2021cites this paper
• The Tools for Aquatic Toxicology within the VEGAHUB System

  2021cites this paper
• HINT: Hierarchical interaction network for clinical-trial-outcome predictions

  2021cites this paper
• In silico analysis of the pharmacodynamics, pharmacokinetics and toxicity of two compounds isolated from Actinidia deliciosa for investigation of their anti-hyperlipemic potential

  2020cites this paper
• Early Prediction of Ecotoxicological Side Effects of Pharmaceutical Impurities Based on Open-Source Non-testing Approaches

  2020cites this paper
• Replacement techniques to reduce animal experiments in drug and nanoparticle development

  2020cites this paper
• Discovery of 2-aryl and 2-pyridinylbenzothiazoles endowed with antimicrobial and aryl hydrocarbon receptor agonistic activities

  2020cites this paper
• In silico models for genotoxicity and drug regulation

  2020cites this paper
• Mathematical Modeling Approaches for Assessing the Joint Toxicity of Chemical Mixtures Based on Luminescent Bacteria: A Systematic Review

  2020cites this paper
• Leveraging high-throughput screening data and conditional generative adversarial networks to advance predictive toxicology

  2020cites this paper
• ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors

  2020cites this paper
• University of Birmingham A critical review of adverse effects to the kidney

  2019cites this paper
• Methodology of aiQSAR: a group-specific approach to QSAR modelling

  2019cites this paper
• Prediction of Protein–Ligand Interaction Based on the Positional Similarity Scores Derived from Amino Acid Sequences

  2019cites this paper
• A chemoinformatics approach for the characterization of hybrid nanomaterials: safer and efficient design perspective.

  2019cites this paper
• Computational prediction of toxicity of small organic molecules: state-of-the-art

  2019influential citation
• Computational Methods of Interspecies Nanotoxicity Extrapolation: A Step toward the Future

  2019cites this paper
• A critical review of adverse effects to the kidney: mechanisms, data sources, and in silico tools to assist prediction

  2018cites this paper
• OPERA models for predicting physicochemical properties and environmental fate endpoints

  2018cites this paper
• In silico identification of protein targets for chemical neurotoxins using ToxCast in vitro data and read-across within the QSAR toolbox† †Electronic supplementary information (ESI) available: Tables S1–S4. See DOI: 10.1039/c7tx00268h

  2018cites this paper
• The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions.

  2018cites this paper
• Performance of In Silico Models for Mutagenicity Prediction of Food Contact Materials

  2018cites this paper
• The effects of structural changes on the anti-microbial and anti-proliferative activities of diimidazolium salts

  2017cites this paper
• Evaluating the mutagenic potential of aerosol organic compounds using informatics-based screening

  2017cites this paper
• Research directions in plant protection chemistry

  2017cites this paper
• Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives.

  2016cites this paper